What is cdh

What is Congenital Diaphragmatic Hernia?

Congenital Diaphragmatic Hernia (CDH) is a structural birth defect affecting the diaphragm, the large muscle that separates the chest cavity from the abdominal cavity and plays a crucial role in breathing. When an opening or weakness in the diaphragm develops during fetal growth, abdominal organs such as the intestines, liver, and spleen can herniate upward into the chest space. This displacement compresses the lungs and heart, interfering with their normal development and function.

Development and Incidence

CDH develops during the first two months of pregnancy when the diaphragm is forming. While the exact cause remains unclear, research suggests genetic and environmental factors may contribute. The condition affects approximately 1 in 2,500 to 1 in 3,500 live births worldwide, with variations among populations. Left-sided defects are more common than right-sided, and some infants have additional genetic syndromes or birth defects alongside CDH.

Prenatal Diagnosis

Modern prenatal ultrasounds can detect CDH as early as 18-20 weeks of pregnancy. Diagnosis involves observing abdominal organs in the chest cavity, measuring lung size, and assessing heart position. Once diagnosed, expectant parents have time to prepare emotionally and logistically. Advanced imaging techniques like fetal MRI provide detailed information about organ positions and lung volumes, helping doctors predict postnatal outcomes and plan delivery strategies.

Postnatal Presentation and Symptoms

Newborns with CDH typically develop symptoms immediately after birth. Respiratory distress manifests as rapid, labored breathing and low oxygen saturation. Cyanosis (bluish skin color) occurs due to inadequate oxygenation. Some infants require immediate intubation and mechanical ventilation. The severity depends on how much lung tissue is present and how many organs have herniated into the chest. Severe cases present with critical illness requiring emergency intervention.

Treatment and Surgery

Initial treatment focuses on stabilizing the infant through mechanical ventilation, supplemental oxygen, and medications to manage pulmonary hypertension. Once the baby is stable, surgeons perform a diaphragmatic repair, moving abdominal organs back into the abdomen and closing the defect with sutures or a synthetic patch. Surgery is usually performed within the first week of life, though timing depends on the infant's stability. Recovery requires weeks to months of intensive care with gradual weaning from respiratory support.

Long-Term Outcomes

Survival rates have improved significantly with advances in prenatal diagnosis and neonatal intensive care, ranging from 50% to 90% depending on defect severity. Surviving children may experience chronic lung disease, feeding difficulties, or gastroesophageal reflux. Many require long-term follow-up with pediatric pulmonologists and specialists. Most children who survive CDH develop normally, though some experience breathing difficulties during physical activity or have lower exercise capacity than their peers.